Understanding GLP-1's broader metabolic effects remains an active area of investigation, particularly regarding its potential interactions with stress hormones like cortisol
Gastrointestinal Side Effects: Nausea (can be severe and can last several days to weeks) Vomiting (can be severe and lead to dehydration) Diarrhea Constipation Abdominal pain Hypoglycemia (Low Blood Sugar): While semaglutide itself is not known to cause hypoglycemia, it may occur when used in combination with other diabetes medications, especially insulin or sulfonylureas
Attempting to manipulate the pen mechanism or extract medication could result in contamination, inaccurate dosing, medication waste, and potential injection site complications
This stepwise escalation principle mirrors the approach used for licensed medicines such as semaglutide (Wegovy, UK SmPC available via the electronic Medicines Compendium) and tirzepatide (Mounjaro, UK SmPC available via the electronic Medicines Compendium), both of which are approved by the MHRA and recommended within relevant NICE guidance for specific indications
Roles of microglial and monocyte chemokines and their receptors in regulating Alzheimers disease-associated amyloid-beta and tau pathologies
The WT C57BL/6 mice were purchased from Jackson Laboratory